ACR Releases Second Research Road Map on Medical Imaging AI
|
By MedImaging International staff writers Posted on 24 Jun 2019 |

Image: New research outlines the challenges, opportunities and priorities for foundational research in AI for medical imaging (Photo courtesy of ABM).
The Journal of the American College of Radiology (JACR) has published a report detailing real-world artificial intelligence (AI) challenges and summarizing the priorities for translational research in AI for medical imaging to help accelerate the safe and effective use of AI in clinical practice. The report is the second part of a road map published in Radiology outlining the challenges, opportunities and priorities for foundational research in AI for medical imaging. The two reports are the outcome of an August 2018 workshop convened by the National Institute of Biomedical Imaging and Bioengineering {(NIBIB) Bethesda, MA, USA} to explore the future of AI in medical imaging.
The second report outlines four key priorities, namely creating structured AI use cases, defining and highlighting clinical challenges potentially solvable by AI; establishing methods to encourage data sharing for training and testing AI algorithms to promote generalizability to widespread clinical practice and mitigate unintended bias; establishing tools for validation and performance monitoring for AI algorithms to facilitate regulatory approval; and developing standards and common data elements for seamless integration of AI tools into existing clinical workflows.
“Radiology has transformed the practice of medicine in the past century, and AI has the potential to radically impact radiology in positive ways,” said Krishna Kandarpa, MD, PhD, co-author of the report and director of research sciences and strategic directions at NIBIB. “This roadmap is a timely survey and analysis by experts at federal agencies and among our industry and professional societies that will help us take the best advantage of AI technologies as they impact the medical imaging field.”
“Our companion paper gave a roadmap to advance foundational machine learning research. But for foundational research to benefit patients, novel algorithms must be evaluated and deployed in a safe and effective manner. This new roadmap paper gives guidance for the clinical translation of AI innovation,” said Curtis P. Langlotz, MD, PhD, report co-author and RSNA board liaison for information technology and annual meeting. “Together, these two connected roadmaps show us how AI not only will transform the work of radiologists and other medical imagers, but also will enhance the delivery of care throughout the clinical environment.”
Related Links:
National Institute of Biomedical Imaging and Bioengineering
The second report outlines four key priorities, namely creating structured AI use cases, defining and highlighting clinical challenges potentially solvable by AI; establishing methods to encourage data sharing for training and testing AI algorithms to promote generalizability to widespread clinical practice and mitigate unintended bias; establishing tools for validation and performance monitoring for AI algorithms to facilitate regulatory approval; and developing standards and common data elements for seamless integration of AI tools into existing clinical workflows.
“Radiology has transformed the practice of medicine in the past century, and AI has the potential to radically impact radiology in positive ways,” said Krishna Kandarpa, MD, PhD, co-author of the report and director of research sciences and strategic directions at NIBIB. “This roadmap is a timely survey and analysis by experts at federal agencies and among our industry and professional societies that will help us take the best advantage of AI technologies as they impact the medical imaging field.”
“Our companion paper gave a roadmap to advance foundational machine learning research. But for foundational research to benefit patients, novel algorithms must be evaluated and deployed in a safe and effective manner. This new roadmap paper gives guidance for the clinical translation of AI innovation,” said Curtis P. Langlotz, MD, PhD, report co-author and RSNA board liaison for information technology and annual meeting. “Together, these two connected roadmaps show us how AI not only will transform the work of radiologists and other medical imagers, but also will enhance the delivery of care throughout the clinical environment.”
Related Links:
National Institute of Biomedical Imaging and Bioengineering
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
X-ray imaging offers limited visualization of soft tissues like cartilage, complicating evaluation of joint pain and degenerative disease. Clinicians often rely on joint-space narrowing as a proxy for... Read more
AI Boosts Breast Cancer Detection and Cuts Screening Workload
Breast cancer screening programs face rising demand and persistent workforce shortages, straining double-reading workflows and delaying care. Early detection is critical to reduce mortality and minimize... Read moreMRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







